(20) evaluated the effect of 2-hydroxy-3-methylanthraquinone (HMA) on lung cancer cells in vitro, aiming to test the hypothesis that HMA may partially inhibit the growth, migration and/or invasion of lung cancer cells by downregulating IL-6-induced JAK2/STAT3 pathway. Here, JAK2 is linked to lung carcinoma.